Company Profiles

driven by the PitchBook Platform

Milestone Pharmaceuticals

Description

Developer of cardiovascular drugs intended to meet the growing medical need related to safety of the cardiac procedure. The company's cardiovascular drug is a potent, self-delivered and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia, enabling patients to treat episodes at home and improve their quality of life.

2005

Founded

PRIVATE

Status

Series C

Latest Deal Type

$55M

Latest Deal Amount

$89M

Total Amount Raised

10

Investors

Description

Developer of cardiovascular drugs intended to meet the growing medical need related to safety of the cardiac procedure. The company's cardiovascular drug is a potent, self-delivered and short-acting nasally-delivered calcium channel antagonist for the episodic treatment of paroxysmal supraventricular tachycardia (PSVT), a cardiac arrhythmia, enabling patients to treat episodes at home and improve their quality of life.

Website:

www.milestonepharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

1111 Drive, Frederik-Philips Boulevard Suite 420 Saint-Laurent, Quebec H4M 2X6Canada +1 (514) 336-0444
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Milestone Pharmaceuticals's full profile, request a free trial.

    Milestone Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Milestone Pharmaceuticals Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BDC Healthcare Venture FundVenture CapitalMinority000 0000000 0000
    Domain AssociatesVenture CapitalMinority000 0000000 0000
    Fonds Bio-InnovationOtherMinority000 0000000 0000
    Fonds de solidarité FTQVenture CapitalMinority000 0000000 0000
    Forbion Capital PartnersVenture CapitalMinority000 0000000 0000
    BDC Healthcare Venture Fund Venture Capital
    Domain Associates Venture Capital
    Fonds Bio-Innovation Other
    Fonds de solidarité FTQ Venture Capital
    Forbion Capital Partners Venture Capital

    Milestone Pharmaceuticals Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Joseph OlivetoChief Executive Officer, President & Board Member
    Philippe Douville Ph.DChief Scientific Officer & Founder
    Jeff LeightonChief Scientific Advisor
    Martin Maguire Ph.DVice President, Chemistry & Manufacturing
    Douglas WightVice President, Drug Development
    Joseph Oliveto Chief Executive Officer, President & Board Member
    Philippe Douville Ph.D Chief Scientific Officer & Founder
    Jeff Leighton Chief Scientific Advisor
    Martin Maguire Ph.D Vice President, Chemistry & Manufacturing
    Douglas Wight Vice President, Drug Development

    Milestone Pharmaceuticals Board Members (11)

    NameRepresentingRoleSinceContact
    Info
    Daniel Omstead Ph.DTekla Capital ManagementPresident & Chief Executive Officer000 0000
    Debra LiebertDomain AssociatesManaging Director000 0000
    Dion MadsenBDC Healthcare Venture FundSenior Managing Partner000 0000
    Ela BorensteinBDC Healthcare Venture FundBoard Member000 0000
    Joseph OlivetoMilestone PharmaceuticalsChief Executive Officer, President & Board Member000 0000
    Daniel Omstead Ph.D President & Chief Executive Officer Tekla Capital Management
    Debra Liebert Managing Director Domain Associates
    Dion Madsen Senior Managing Partner BDC Healthcare Venture Fund
    Ela Borenstein Board Member BDC Healthcare Venture Fund
    Joseph Oliveto Chief Executive Officer, President & Board Member Milestone Pharmaceuticals
    Request full access to PitchBook